利用率高企或超100%

港股IPO招股书披露先例 · 26 家公司,26 项

此类事项指部分或全部产线的设计产能接近饱和乃至超负荷运行,涉及产能可持续性与产能过剩风险的披露问题。招股书一般在概要、风险因素、业务及财务资料章节披露,申请人通常按产品线、生产基地或设施列示各期设计产能与利用率,解释超负荷源于延长生产时间、增加排班或灵活的产能管理,并说明扩建产线、新建基地等扩产安排及资金来源,部分亦提示需求波动下的产能过剩或执行风险。

2025-06-13Prospectus
浙江三花智能控制股份有限公司ZHEJIANG SANHUA INTELLIGENT CONTROLS CO., LTD.02050.HK

产能利用率达约84%至92%的较高水平

Our total production capacity utilization rate was 83.8%, 92.2% and 91.2%, respectively, for 2022, 2023 and 2024.

Business · 第 207 页

In order to grow our business, meet the increasing demand from our customers and capture the potential growth opportunities in the refrigeration and air-conditioning product components, automotive components and the electromechanical actuators for bionic robot in China and globally, we plan to use the net proceeds of the Global Offering and our internal funds to expand our production capacity and upgrade our factories in China and overseas.

Business · 第 210 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-03-19Prospectus
舒宝国际集团有限公司Soft International Group Ltd02569.HK

女性护理及无纺布生产线利用率超100%

The utilisation rate of our feminine care product production lines increased from approximately 1.5% for FY2021 and 34.9% for FY2022 to approximately 138.3% for FY2023 and 100.7% for 9M2024, respectively, mainly due to an explosive growth of our D2C feminine care product sales since FY2023.

Business · 第 203 页

In this regard, we entered into a contract to acquire full-servo machine for setting up three additional feminine care production lines at a consideration of approximately RMB12.0 million, of which approximately RMB3.6 million as capital commitment has been committed.

Business · 第 203 页

During the Track Record Period, our average utilisation rate for our babycare product production lines were approximately 51.0%, 68.8%, 84.1%, and 60.0%, respectively; our average utilisation rate for our feminine care production lines were approximately 1.5%, 34.9%, 138.2%, and 100.7%, and our average utilisation rate for our adult incontinence production lines were approximately 13.7%, 7.4%, 14.7%, and 27.2%, respectively, for the same periods.

Financial Information · 第 276 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-03-17Prospectus
南山铝业国际控股有限公司Nanshan Aluminium International Holdings Limited02610.HK

设计年产能200万吨且利用率逾90%

As at the Latest Practicable Date, our production base, comprised our Phase I Alumina Production Project and Phase II Alumina Production Project, had an aggregate designed annual production capacity of two million tons of alumina, and we maintained a utilisation rate of over 90% during the Track Record Period.

Financial Information · 第 317 页

Going forward, we are also expanding our production capacity by engaging in our New Alumina Production Project at our production base, which is expected to have a designed annual production capacity of two million tons of alumina.

Financial Information · 第 318 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-09-27Prospectus
荣利营造控股有限公司Wing Lee Development Construction Holdings Limited09639.HK

自有建筑机械使用率连续三年达100%

For FY2021/22, FY2022/23 and FY2023/24, the utilisation rate of our major construction machinery and equipment was 100%, 100% and 100%, respectively.

Business · 第 228 页

During FY2023/24, we acquired new machinery to supplement the machinery that have short remaining useful life or have been fully depreciated in our fleet of machinery.

Business · 第 228 页

Our executive Directors consider that continuing and further investments in machinery are necessary in order to cope with our business development and increase our overall operational efficiency and capacity in performing our site works.

Business · 第 233 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-06-07Prospectus
武汉有机控股有限公司Wuhan Youji Holdings Ltd.02881.HK

武汉厂利用率超100%并扩充产能

The utilization rates were 102.4%, 122.8% and 104.0% for our Wuhan Production Plant, and 91.8%, 91.7% and 86.4% for our Qianjiang Xinyihong Production Plant for the years ended December 31, 2021, 2022 and 2023.

Financial Information · 第 259 页

In anticipation of the industry trends and our business growth in the larger organic synthetic chemical products industry, and to better serve our clients in the PRC and the global market, we have undertaken efforts to expand our current production capacity.

Financial Information · 第 259 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2023-08-24Prospectus
宜明昂科生物医药技术(上海)股份有限公司ImmuneOnco Biopharmaceuticals (Shanghai) Inc.01541.HK

中试产能自2021年以来约满负荷运行

Our pilot manufacturing facilities have operated at approximately 100% utilization rate since 2021, successfully supporting various preclinical studies, IND applications and early-stage clinical trials of some of our drug candidates.

Business · 第 308 页

However, the scale of our pilot production lines is insufficient to meet the demand for commercial sales of our drug candidates in the near future.

Business · 第 309 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us